Excipients Market | Size | Share | Industry Report 2018-2025

Pharmaceutical Excipient Market is is Expected to Reach US$ XX Bn by 2025, Due to Advancements in Functional Excipients
Analyst Speak:

“The Pharmaceutical Excipient Market is anticipated to reach about US$ XX Bn by 2025, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” owing to advancements in functional excipients.

Precision Business Insights (PBI) in its report titled “Pharmaceutical Excipient Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The pharmaceutical excipient market size was accounted for US$ XX Bn in 2018 and anticipated to account for US$ XX Bn by 2025. The growing pharmaceutical market along with the advancements in functional excipients, growing generics market propelled by the patent cliffs, and the rapidly growing biopharmaceuticals sector are the major factors driving the growth of the market. Factors such as the emergence of multifunctional & co-processed excipients, shifting focus of pharmaceutical manufacturing to emerging markets, and the growing biologics and biosimilars industry also present significant opportunities for the growth of excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.

Pharmaceutical excipient market segmented on the basis of product type, function, end-user, and geography.

Request Sample Report:

https://precisionbusinessinsights.com/request-sample?product_id=15952

Parenteral Formulation Segment Expected to Dominate the Market

Based on formulation type, the pharmaceutical excipient market is segmented into oral, topical, parenteral, and other formulations. The parenteral formulations segment is expected to grow at the highest CAGR owing to the increasing incidence of infectious diseases, such as hepatitis, tuberculosis, cardiovascular diseases, diabetes, and cancer, where parenteral formulations are used as a major line of treatment. Also, the emergence of new biologics and biosimilars delivered through the parenteral route will contribute to the market growth.

Organic Chemicals Will Dominate the Revenue Share.

Based on product type, the pharmaceutical excipient market is segmented into organic, inorganic and petrochemicals. The organic chemical excipients segment accounted for the largest share of the pharmaceutical excipients market, in 2017. This can be attributed to the use of these excipients in majorly all of the pharmaceutical formulations. They offer advantages such as increased efficacy in oral delivery of poorly soluble molecules along with increased compressibility and flow ability properties.

Europe, Accounts for Major Revenue Share for Pharmaceutical Excipient Market

Precision Business Insights (PBI) pharmaceutical excipient market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, Europe accounted for major revenue share followed by North America. As it dominates in in terms of the size of the excipients market globally. Asia-Pacific is witnessed to exhibit a significant CAGR during the forecast period due to various opportunity owing to the availability of lower labour cost, skilled work force in and low cost of raw materials.

New Product Launch Play Vital Role in Pharmaceutical Excipient Market

The increased R&D investment from pharmaceutical companies, research organizations and biotech companies are expected to create demand for pharmaceutical excipients. For instance, in April 2017, Lubrizol Corporation’s Skin Essentials division launched new acrylate-based polymeric emulsifier Pemulen EZ-4U
Key player’s profiles in the report are Some of the major players in Global Pharmaceutical Excipients Market include Evonik Industries Ag,FMC Corporation, The Dow Chemical Company, Ashland, Inc., Basf Se, Ferro Corporation, P&G Chemicals, Akzo Nobel NV, and Croda International PLC among others.

Detailed Segmentation

By Product Type

o Inorganic Chemicals
 Calcium Phosphates
 Calcium Carbonate
 Calcium Sulphate
 Halides
 Metallic Oxides
o Organic Chemicals
 Carbohydrates
 Sugar
 Starch
 Cellulose
o Petrochemicals
 Glycols (alcohol)
 Povidones polymers
 Mineral Hydrocarbons
 Oleochemicals
 Gelatin (Proteins)

By Function Type

o Fillers and Diluents
o Coatings
o Binders
o Disintegrants
o Flavouring Agents
o Colorants
o Others

By Dosage Form Type

o Tablets
o Capsules
o Liquids
o Injections
o Others

By End-User Type

o Pharmaceutical Companies
o Research Labs
o Biotech Companies
o Other Industries

Geography

o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Russia
 Spain
 Italy
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 ASEAN
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Chile
 Rest of Latin America
o Middle East and Africa
 South Africa
 Saudi Arabia
 Rest of MEA

For More Information:
https://precisionbusinessinsights.com/market-reports/global-pharmaceutical-excipients-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.